Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Compounded Aseptic Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

This public procurement record has 2 releases in its history.

Award

13 Mar 2020 at 00:00

OJEU - F3 - Contract Award Notice
Tender

25 Sep 2019 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The Common Services Agency, known as NHS National Services Scotland (NSS), has initiated a tender for the supply of "Compounded Aseptic Medicines". This procurement falls within the health industry sector and is set in Edinburgh, UK, where it aims to create a framework agreement for the ready-to-use aseptically compounded medicines to be delivered to various NHS entities across Scotland. The procurement method is open, and key dates include a submission deadline of 28 October 2019, with the award decisions commencing from that date. This framework includes a total estimated value of £74,200,000, with the potential for a twelve-month extension.

This tender presents significant opportunities for businesses specialising in the pharmaceutical and medical supplies sectors, particularly those experienced in aseptic compounding and quality management systems. Suppliers with the capability to meet NHS procurement standards and demonstrate technical requirements, such as possessing a valid MHRA Manufacturing Specials License, will be ideal candidates for the tender. Additionally, businesses looking to expand in the healthcare supply chain can benefit from the framework, which allows for maximum participation of three suppliers per lot, encouraging competition and collaborative partnerships.

How relevant is this notice?

Notice Information

Notice Title

Compounded Aseptic Medicines

Notice Description

This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra(r)), (Remicade(r)), (Remsima(r)) Nivolumab Pembrolizumab Pertuzumab The Authority has awarded all presentations within this Lot to a single supplier.

Renewal: This framework includes the option(s) to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera(r)), (Rixathon(r)), (Truxima(r)) The Authority has awarded all presentations within this Lot to a single supplier.

Renewal: This framework includes the option(s) to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin(r)), (Herzuma(r)) Vincristine The Authority has awarded all presentations within this Lot to a single supplier.

Renewal: This framework includes the option(s) to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

All Other Presentations

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly(r)) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti(r)), (Ontruzant(r)) Trastuzumab Subcutaneous Vedolizumab Each product line was treated as an individual Lot and awarded as an unranked multi-supplier framework.

Renewal: This framework includes the option(s) to extend for up to a total period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000595933
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR383681
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£74,200,000 £10M-£100M
Lots Value
£74,200,000 £10M-£100M
Awards Value
Not specified
Contracts Value
£63,213,954 £10M-£100M

Notice Dates

Publication Date
13 Mar 20206 years ago
Submission Deadline
28 Oct 2019Expired
Future Notice Date
Not specified
Award Date
14 Feb 20206 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
3
Supplier Names

Baxter Healthcare Ltd

ITH Pharma Limited

Qualasept Limited t/a Bath ASU

Further Information

Notice Documents

  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP367362
    Compounded Aseptic Medicines - This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
  • https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR383681
    Compounded Aseptic Medicines - This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland. The Goods have been separated into four (4) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...